M E D I C A T I O N S & Sean M. Jeffery
|
|
- Magnus Turner
- 5 years ago
- Views:
Transcription
1 M E D I C A T I O N S & Sean M. Jeffery
2 Subtitle Could my medications be causing me to fall? A discussion on medication safety and falls prevention.
3 Contact Information & Disclosure Sean M. Jeffery, PharmD, CGP, FASCP, FNAP, AGSF Clinical Professor, Department of Pharmacy Practice University of Connecticut School of Pharmacy & Director, Clinical Pharmacy Services Integrated Care Partners Hartford Healthcare Group Consultant CVS/Caremark National Pharmacy and Therapeutics Committee
4 Awesome Session Educational Objectives Identify medication risk factors associated with falling Discuss strategies to minimize fall risk from medications
5
6
7
8
9 A minority of patients account for the majority of morbidity and cost Percent of total expenditure 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 97% 80% 64% 49% 22% 3% Top 1% Top 5% Top 10% Top 20% Top 50% Bottom 50% Percent of population Conwell, Cohen, Characteristics of people with high medical expenses in the USA civilian non-institutiona lized population AHRQ March 2005
10 Opportunity to Drive Change
11 The move to alternative payment models requires a fundamental change in how we organize healthcare Traditional FFS Sick Care / Hospital Care Alternative Payment Value- Based Care Population Health + Sick Care / Hospitals Episodic care Longitudinal care Individuals practicing in silos Variations in care Team-based, coordinated, integrated care Evidence-based standards
12
13
14 TWO-THIRDS OF ADVERSE EVENTS POST-DISCHARGE ARE RELATED TO MEDICATIONS MORE THAN 80% PATIENTS HAVE AT LEAST ONE MEDICATION ISSUE 30% OF READMISSIONS ARE MEDICATION RELATED Omission 45% Duplicate 16%
15 Too many medications + Too complicated + Too Costly + Not aligned with patient s goals of care = hot mess Drugs don t work in people who don t take them. C. Everett Koop, MD
16
17 I am having accidents Who: an 85 year old female living alone in her house PMHx: HF w/ 1+ peripheral edema HTN GERD Chronic Pain from OA, spinal stenosis Urinary Incontinence Issue: Patient wants to change diuretics. Is having difficulty getting to the bathroom on time. Transitional Care Case Manager is concerned about medications. Comprehensive medication management consult performed with patient, pharmacist and TCCM nurse.
18 Current Medications 1. Lorazepam1 mg po BID for anxiety 2. Amitriptyline 100 mg po qhs 3. Oxybutynin ER 10 mg po once daily 4. Omeprazole 40 mg po BID 5. OxyContin 20 mg po BID 6. Gabapentin 300 mg po QID 7. Ipratropium Bromide 0.06% nasal solution 8. Claritin 10 mg po once daily 9. Verapamil HCl ER 240 mg po qhs 10. Potassium Cl 20 meq po once daily 11. Metolazone 2.5 mg 1 tab po QOD 12. Bumetanide 4 mg po once daily 13. Furosemide 60 mg po once daily 14. Spironolactone 50 mg po once daily
19 OTC Meds 13. Glucosamine Chondroitin Complex 1 tab po daily 14. Calcium Vit. D 2 tablets po once daily 15. Vit. D 2000 Units 16. Multivitamins 17. Vit. B complex 18. Vit. E 400 Units 19. Co Q Fish oil 21. Folic acid 22. Ginkgo Bilobacaps 23. Melatonin 24. Acidophilus caps 25. Metamucil 26. PEG 3350 Oral powder 27. Sennokot 8.6mg
20 Reconciled Medications 1. Lorazepam 1 mg po BID for anxiety 2. Amitriptyline 100 mg po qhs 3. Oxybutynin ER 10 mg po once daily 4. Omeprazole 40 mg po BID 5. OxyContin 20 mg po BID 6. Gabapentin 300 mg po QID 7. Ipratropium Bromide 0.06% nasal soln 8. Claritin 10 mg po once daily 9. Verapamil HCl ER 240 mg po qhs 10. Potassium Cl 20 meq po once daily 11. Metolazone 2.5 mg 1 tab po QOD 12. Bumetanide 4 mg po once daily 13. Furosemide 60 mg po once daily 14. Spironolactone 50 mg po once daily 13. Glucosamine Chondroitin 1 tab po daily 14. Calcium Vit. D 2 tabs po once daily 15. Vit. D 2000 IU 16. Multivitamins 17. Vit. B complex 18. Vit. E 400 IU 19. Co Q Fish oil 21. Folic acid 22. Ginkgo Biloba caps 23. Melatonin 24. Acidophilus caps 25. Metamucil 26. PEG 3350 Oral powder 27. Sennokot 8.6mg
21 Courtesy Troy Trygstad, PharmD, PhD: CCNC
22 System Hurdles Data? Interoperability/Availability? No standard process
23 Provider Hurdles No standard process Time Consuming Knowledge and skills Patient Expectations
24 Patient Hurdles
25 Reconciled Medications 1. Lorazepam 1 mg po BID for anxiety 2. Amitriptyline 100 mg po qhs 3. Oxybutynin ER 10 mg po once daily 4. Omeprazole 40 mg po BID 5. OxyContin 20 mg po BID 6. Gabapentin 300 mg po QID 7. Ipratropium Bromide 0.06% nasal soln 8. Claritin 10 mg po once daily 9. Verapamil HCl ER 240 mg po qhs 10. Potassium Cl 20 meq po once daily 11. Metolazone 2.5 mg 1 tab po QOD 12. Bumetanide 4 mg po once daily 13. Furosemide 60 mg po once daily 14. Spironolactone 50 mg po once daily 13. Glucosamine Chondroitin 1 tab po daily 14. Calcium Vit. D 2 tabs po once daily 15. Vit. D 2000IU 16. Multivitamins 17. Vit. B complex 18. Vit. E 400 IU 19. Co Q Fish oil 21. Folic acid 22. Ginkgo Biloba caps 23. Melatonin 24. Acidophilus caps 25. Metamucil 26. PEG 3350 Oral powder 27. Sennokot 8.6mg
26 How could we, as healthcare providers, be better stewards of patient medications?
27 MEDICATIONS AS A RISK FACTOR FOR FALLS Data mainly from observational studies Falls typically not included in adverse event reporting Cause of falls usually multifactorial Review of medications is a primary National Patient Safety Goal Suggested to review medication and alcohol use as part of falls evaluation TJC 2011 LTC/Home Care Patient Safety Goals
28 Drugs with High Risk for Serious Adverse Effects Warfarin Hypoglycemics Digoxin 1/3 of all ED visits in Older adults
29 Polypharmacy or Polymedicine?
30 Where do you draw the line? DK
31 NUMBER OF MEDICATIONS AND RISK Study published in 2005 via questionnaire Looked at 6928 adults over the age of 55 years Polypharmacy was risk factor for falls when patient was taking one high risk medication Polypharmacy = 3 to 4 medications High risk medications: Hypnotics Benzodiazepines Anxiolytics Diuretics Br J Clin Pharmacol Feb.
32 POLYPHARMACY AS A RISK FACTOR FOR FALLS Br J Clin Pharmacol Feb.
33 MEDICATION CLASSES IMPLICATED IN FALLS Sedatives Hypnotics Antidepressants Benzodiazepines Analgesics Anticonvulsants Antihistamines Diuretics Beta Blockers Anticoagulants Antihypertensive Agents Hypoglycemic Medications Anticholinergic Agents
34 Discuss Medication Adverse Effects That Contribute to Falls
35 PSYCHOTROPIC MEDICATIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Medication Pooled Odds Ratio 95% Confidence Interval Any psychotropic Neuroleptics Sedatives/hypnotics Any antidepressant Tricyclic antidepressants Benzodiazepines JAGS 1999; 47: 30-9
36 ANTIPSYCHOTICS Conventional Atypical Adverse Effects Chlorpromazine Aripiprazole Sedation Haloperidol Clozapine Extrapyramidal symptoms (EPS) Perphenazine Olanzapine Anticholinergic Promazine Quetiapine effects Thioridazine Risperidone Orthostatic hypotension Thiothixene Ziprasidone Less Anticholinergic: aripiprazole, haloperidol, quetiapine, and risperidone J Am Geriatc Soc Apr;60(4):
37 NON-BENZODIAZEPINE HYPNOTICS AND SEDATIVES Hypnotics/Sedatives Zolpidem Zaleplon Ezopiclone Chloral hydrate Meprobamate Adverse Effects Dizziness Somnolence Drowsiness Balance disorder Confusion Sleep-walking Performing activities while sleeping Avoid Use: similar effects as benzodiazepines - delirium, falls, fracture risk, hangover feeling J Am Geriatc Soc Apr;60(4):
38 ANTIDEPRESSANTS Tricyclic Antidepressants Nortriptyline Amitriptyline Desipramine Doxepin Adverse Effects Anticholinergic side effects: blurred vision, confusion, drowsiness **On Beer s List due to these adverse effects Orthostatic hypotension Drowsiness EKG abnormalities Imipramine Lexi-Comp DI Handbook
39 ANTIDEPRESSANTS Antidepressants Selective Serotonin Reuptake Inhibitors (SSRIs): Citalopram Fluoxetine Paroxetine Fluvoxamine Escitalopram Other: Bupropion Duloxetine Mirtazapine Trazodone Adverse Effects Drowsiness Orthostatic hypotension EKG abnormalities Anticholinergic effects Lexi-Comp DI Handbook
40 ANTICHOLINERGIC MEDICATIONS Anticholinergic Medications Antihistamines: Diphenhydramine, Chlorpheniramine, Brompheniramine Ranitidine Oxybutynin Tolterodine Meclizine Scopolamine Benztropine Amantadine Adverse Effects Dizziness Drowsiness Blurred vision Urinary retention Mental status changes Lexi-Comp DI Handbook
41 ANTICHOLINERGICS: HIDDEN SOURCES OVER THE COUNTER
42 BENZODIAZEPINES Benzodiazepine Short and Intermediate Acting: Alprazolam Lorazepam Oxazepam Temazepam Long Acting: Chlordiazepoxide Clonazepam Diazepam Flurazepam Adverse Effects Dizziness Sedation Confusion Delirium Hypotension Unsteadiness
43 ANTICONVULSANTS Anticonvulsants Older Agents: Carbamazepine Phenytoin Phenobarbital Primidone Ethosuximide Valproic Acid Newer Agents: Topiramate Zonisamide Lamotrigine Levetiracetam Gabapentin Adverse Effects Ataxia Confusion Dizziness Sedation Somnolence Hypotension Impaired coordination Visual disturbance
44 CARDIOVASCULAR MEDICATIONS Cardiovascular Agent Beta Blockers ACE Inhibitors/ ARBs Calcium channel blockers Diuretics Centrally acting agents Alpha blockers Vasodilators Nitrates Adverse Effects Orthostatic hypotension Bradycardia Dizziness Increased urination à increased ambulation Drowsiness Fatigue Confusion
45 ANTICOAGULANTS Anticoagulant Warfarin Heparin Enoxaparin Fondaparinux Novel anticoagulants: Dabigatran Rivaroxaban Apixaban Edoxaban Adverse Effects Bleeding
46 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) NSAID Non-selective: Aspirin > 325mg/day Ibuprofen Naproxen Meloxicam Piroxicam Diclofenac Etodolac Ketorolac Indomethacin COX-selective: Celecoxib Adverse Effects Bleeding Dizziness Drowsiness Lightheadedness Visual disturbances
47 NARCOTICS Narcotic Analgesic Morphine Oxycodone Hydromorphone Fentanyl Methadone Codeine Hydrocodone Butorphanol Opium Tramadol Adverse Effects Sedation Drowsiness Dizziness Confusion Mental status changes Hypotension Constipation
48 INJECTABLE HYPOGLYCEMICS Hypoglycemic Insulin: Aspart Lispro Glulisine Regular NPH Glargine Detemir Other Injectables: Exenatide Pramlintide Adverse Effects Hypoglycemia Dizziness Somnolence Blurred vision
49 ORAL HYPOGLYCEMICS Hypoglycemic Sulfonylureas: Glipizide Glyburide Glimepiride Alpha-glucosidase inhibitors: Acarbose Miglitol Meglitindes: Nateglinide Repaglinide Thiazolidines: Pioglitazone Biguanides: Metformin Adverse Effects Hypoglycemia Dizziness Somnolence Blurred vision Diarrhea
50 Strategies to Reducing Risk of Medication-Related Falls
51 THE ROLE OF THE PHARMACIST Drug information resource Medication review Prior to and following a fall Educate patients and caregivers Anticipate adverse effects Recommend alternate regimen Considerations for special populations
52 SAFER MEDICATION USE IN HIGH RISK PATIENTS Keep up-to-date medication list All patients should carry on their person Include over-the-counter medications Consider one drug for multiple indications Consider overall benefit vs. risk when prescribing Closely monitor for adverse effects Consider all new symptoms as possibly drug-related Perform medication review and reduction
53 MINIMIZE MEDICATIONS Use minimum effective dosing of fewest medications Change to safer medication Withdrawal of unnecessary medications Taper or gradual dose reduction if necessary i.e. Psychotropic medication withdrawal Non-pharmacologic measures in place of medications
54
55 MANAGE ORTHOSTATIC HYPOTENSION Non-pharmacologic measures Sit for 2 to 3 minutes before standing Clench hands or pump ankles before standing Compression stockings Liberalize salt intake if appropriate Add post-prandial caffeinated coffee á¹€edications to increase blood pressure: Midodrine Fludrocortisone 2.5 to 10 mg three times daily 0.1 mg one to three times daily
56
ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY
ANTIDEPRESSANTS Serotonin Selective Reuptake Inhibitors citalopram 10, 20, 40 mg, 10 mg/5cc $ 0.40 No escitalopram 10, 20 mg $ 2.60 Yes fluoxetine 10, 20 mg, 20 mg/5 ml $ 0.40 Yes fluvoxamine 25, 50, 100
More informationKatee Kindler, PharmD, BCACP
Speaker Introduction Katee Kindler, PharmD, BCACP Current Practice: Clinical Pharmacy Specialist Ambulatory Care, St. Vincent Indianapolis Assistant Professor of Pharmacy Practice, Manchester University,
More informationMeds and Falls: Keep in Step with your Meds
Meds and Falls: Keep in Step with your Meds Donna Bartlett PharmD, CGP, RPh Associate Professor-Pharmacy Practice MCPHS University Clinical Pharmacist-MCPHS University- Pharmacy Outreach Program donna.bartlett@mcphs.edu
More informationPalliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers
Palliative Care Drug Plan (Plan P) Formulary List of drugs PharmaCare covers This formulary is current as of February 11, 2010. Important Notes: Pharmacists must submit a claim on PharmaNet at the time
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationMedicine Related Falls Risk Assessment Tool (MRFRAT)
Medicine Related Falls Risk Assessment Tool (MRFRAT) The Medicine Related Falls Risk Assessment tool (MRFRAT) in Appendix 1 is designed to help identify patients at risk of falls due to their current medicine
More informationManagement of Delirium in Hospice Patients
Presentation Objectives Management of Delirium in Hospice Patients Lynn Williams, BSPharm Clinical Pharmacist Hospice Pharmacy Solutions Identify the clinical features of delirium Understand the underlying
More informationMedicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay
Medicine Related Falls Risk Assessment Tool (MrFRAT) User Guide for Age Related Residential Care Facility Staff in Hawke s Bay (Revised edition November 2015) The Medicine Related Falls Risk Assessment
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationMedications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy
Medications Contributing to Falls Kate Niemann, PharmD BCGP AuBurn Pharmacy Why Are Falls Important? Leading cause of injury in elders Costs to the system (CDC, 2008) ER Visits: 2.2 million $28.2 billion
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationGeriatric Pharmacology. Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center
Geriatric Pharmacology Kwi Bulow, M.D. Clinical Professor of Medicine Director, Academic Geriatric Resource Center Silver Tsunami 2010: 40 million (13%) 2030: 72 million (20%) Baby Boomers (1946-1964)
More informationFall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)
Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach) Chinenye Emereole, Pharm.D. Clinical Pharmacist Hospice Pharmacy Solutions Objectives Assess and identify hospice patients who
More informationFalls most commonly seen in RACFs are due to tripping, slipping and stumbling (21.6%). Falling down stairs is relatively uncommon in
This Presentation Medications and Falls Dr Peter Tenni M Pharm (Curtin), PhD (UTAS) AACPA Director, CPS A fall is an event which results in a person coming to rest inadvertently on the ground or floor
More informationChitra Fernando, MD March 18, 2008
Chitra Fernando, MD March 18, 2008 Definition Statistics Risk factors Why older adults are more prone to ADE Manifestations Inappropriate medications for older adults What can be done to minimize adverse
More information1/21/2016 UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE OBJECTIVES AGING GOALS BEERS CRITERIA
UPDATE ON THE AMERICAN GERIATRICS SOCIETY 2015 BEERS CRITERIA DISCLOSURE I have no financial conflict of interest to disclose. Lacey Charbonneau, Pharm.D. PGY-1 Community Practice Resident Baptist Medical
More informationNorthSTAR. Pharmacy Manual
NorthSTAR Pharmacy Manual Revised October, 2008 Table of I. Introduction II. III. IV. Antidepressants New Generation Antipsychotic Medications Mood Stabilizers V. ADHD Medications VI. Anxiolytics and Sedative-Hypnotics
More informationAlaska Medicaid 90 Day** Generic Prescription Medication List
1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL
More informationForensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
More informationHave You Ever Wondered
Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,
More informationMedicines Formulary BNF Section 4 Central Nervous System
Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationPOLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE
POLYPHARMACY IN OLDER ADULTS AND BEERS CRITERIA UPDATE Jeannie Kim Lee, PharmD, BCPS, CGP Clinical Pharmacy Director College of Pharmacy The University of Arizona Learning Objectives: State the risks of
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),
More informationStep Therapy Medications
Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,
More informationCOMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK
COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK Robert L Alesiani, PharmD, CGP Chief Pharmacotherapy Officer CareKinesis, Inc. (a Tabula Rasa Healthcare Company) 2 3 4 5 Pharmacogenomics
More informationStudy Guidelines for Quiz #1
Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationSMOKING AND DRUG INTERACTIONS
Medicines Information Centre Pharmacy Department UK Medicines Information SMOKING AND DRUG INTERACTIONS Introduction Smoking rates are significantly higher among people with mental health problems. It
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
More information2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)
2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+) In some cases, UCare requires you to first try certain drugs to
More informationDrug Adherence Assessment Report
Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationPsychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA
Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA Goals of Medications Use least number at lowest dose to get
More informationMedication Use in Older Adults
Medication Use in Older Adults F. Michael Gloth, III, MD, AGSF, FACP, CMD Clinical Professor Department of Geriatrics, Florida State University College of Medicine Associate Professor of Medicine Division
More informationAMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details
AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED RELEASE PRIOR CLAIM FOR AMANTADINE HCL IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS. 1 ANTICONVULSANTS
More information2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources
Drugs and Dementia in the Hospice Patient Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources 1 Drug Therapy: Targeted at Symptoms Cognitive: Impaired abstract thinking Impaired
More informationHigh risk medications in the elderly/ Beers criteria updates
High risk medications in the elderly/ Beers criteria updates Date- 9/9/2016 Matt Just, Pharm.D., CGP and Jordan Wolf, Pharm.D., CGP Thrifty White Pharmacy Wi-fi Information: NETWORK: EC-CTR PASSWORD: westgate252
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY
2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017
Effective: 01/01/2017 Updated 11/2016 ANTI-INFLAMMATORY AGENTS - GI DIPENTUM PRIOR CLAIM FOR BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS. ANTICONVULSANTS APTIOM BANZEL FYCOMPA GABITRIL OXTELLAR XR POTIGA
More informationINTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore
More information3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.
Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED
More informationDrugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD
Drugs, Sleep & Wakefulness Brian Koo Reena Mehra MD MS Kingman Strohl MD Things To Keep In Mind Many drugs effect sleep either causing insomnia or sedation Disruption of sleep and wakefulness may not be
More informationOakwood Healthcare Low Cost Drug List for OHSCare & BCN
Oakwood Healthcare Low Cost Drug List for OHSCare & BCN ACETAMINOPHEN-CODEINE ELIXIR Analgesic 240 720 ACYCLOVIR CAP 200MG Antiviral 30 90 AKTOB 0.3% EYE DROPS Miscellaneous 5 15 ALBUTEROL INH SOL 0.083%
More informationGeri-PARDY! (2015 Beers Criteria) Pharmacology Edition
Geri-PARDY! Pharmacology Edition (2015 Beers Criteria) Aurelio Muyot, MD, AGSF, FACP Assistant Professor College of Osteopathic Medicine Touro University Nevada Objectives Review the 2015 Beers Criteria
More informationPotentially Inappropriate Medication Use in Older Adults 2015 Latest Research
Home Resources Potentially Inappropriate Medication Use in Older Adults 2015 Resources Potentially Inappropriate Medication Use in Older Adults 2015 Latest Research Drugs and Categories of Drugs What these
More informationPRESCRIBING IN THE ELDERLY. CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas
PRESCRIBING IN THE ELDERLY CARE HOME PHARMACY TEAM Bhavini Shah, Eleesha Pentiah & Puja Vyas LEARNING OUTCOMES Medicines Optimisation The effects of aging on health and medicines. Polypharmacy Acute Kidney
More informationMedications and Children Disorders
Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for
More informationPharmacology in the Elderly
Pharmacology in the Elderly James Hardy Geriatrician, Royal North Shore Hospital A recent consultation Aspirin Clopidogrel Warfarin Coloxyl with senna Clearlax Methotrexate Paracetamol Pantoprazole Cholecalciferol
More informationProvider Toolkit PFFS/PPO
Provider Toolkit 2014 2015 Y0067_PR_PhysTlkt_0514_IA 05/14/2014 PFFS/PPO TABLE OF CONTENTS Sample Letter from Physician to Patient...4 HEDIS Quick Reference Guide...5 High Risk Medication Formulary Alternative
More informationDisclosures. Outline. Epidemiology. Medication Management in the Elderly. In 2008 pts age 65 and older represented 40% of all hospitalized adults
Medication Management in the Elderly Disclosures Melissa Stevens MD Atlanta VA Medical Center Assistant Professor Emory University Department of Medicine I have no significant financial interest or other
More informationDid you know that some medications can be harmful to people 65 years or older?
Did you know that some medications can be harmful to people 65 years or older? What s the risk? Some medications can be dangerous to people 65 years of age or older. As we age, our bodies change. These
More informationDeconstructing Polypharmacy. Alan B. Douglass, M.D. Director
Deconstructing Polypharmacy Alan B. Douglass, M.D. Director Recognize this patient? Mrs. Brown- 82 years young Active Medical Problems Hypertension Hyperlipidemia Type 2 Diabetes Peripheral edema Osteoarthritis
More informationA Step Forward: Promoting Independence through Falls Prevention
A Step Forward: Promoting Independence through Falls Prevention 2014 Geriatric Update Meharry Consortium Geriatric Education Center A Step Forward: Promoting Independence through Falls Prevention Moderator:
More informationMentoring Session: Participant Cases
Handout for the Neuroscience Education Institute (NEI) online activity: Mentoring Session: Participant Cases The Case: 55-year-old patient with depression and anxiety The Question: What to do when antidepressants
More informationUniversity of Hawaii Center on Aging
University of Hawaii Center on Aging. Supported in part by a cooperative agreement No. 90AL0011-01-00 from the Administration on Aging, Administration for Community Living, U.S. Department of Health and
More informationPsychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan
Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment
More informationChapter 4 ~ Central nervous system
Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS
More informationUsing the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit
Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit Target Audience: Pharmacists ACPE#: 0202-9999-18-056-L01-P Activity Type: Application-based Disclosures Kathleen
More informationPolicy Evaluation: Low Dose Quetiapine Safety Edit
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University 500 Summer Street NE, E35, Salem, Oregon 97301 1079 Phone 503 947 5220 Fax 503
More informationSTOPP and START criteria October 2011
# START and STOPP are newer criteria to identify potentially inappropriate medications in elderly, including drug drug and drug disease interactions, drugs which increase risk of falls and drugs which
More informationBack to Basics: The Basics of Medication Monitoring
DIAMOND PHARMACY SERVICES Back to Basics: The Basics of Medication Monitoring Presented by: Dr. Deborah Milito, Pharm. D., CGP. Director of Clinical and Consultant Services Skilled Division Annual Educational
More informationPrevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College
Prevention of Medication-Related Falls Through Appropriate Medication Use Clay Sprouse, MEd., CPhT Piedmont Technical College Disclosure I have no relevant financial or nonfinancial relationships to disclose
More informationSafe Medication Use. Holly Divine, PharmD, CGP, CDE. University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science
Safe Medication Use in the Older Adult Holly Divine, PharmD, CGP, CDE Associate Professor University of Kentucky College of Pharmacy Department of Pharmacy Practice & Science Objectives Know the principles
More informationWorkshop 4: Preventing Falls through Medication Vigilance
Workshop 4: Preventing Falls through Medication Vigilance Nancy L. Losben, R.Ph., CCP, FASCP, CG Chief Quality Officer Omnicare, Inc. & Diane C. Vaughn, RN, C-DONA/LTC, LNHA VP, Clinical Services Benedictine
More informationGeriatric Pharmacology
Geriatric Pharmacology Janice Scheufler R.Ph.,PharmD, FASCP Clinical Pharmacist Hospice of the Western Reserve Objectives List three risk factors for adverse drug events in the elderly Discuss two physiological
More information(D) Standard Indications Included (Refer to Appendix A for list of medications)
Name of Policy:PolicyNumber: PRN Indications }-.+-`-+,tr---fi::-'..1- :-` -.,-_ -` E-..,',,=.:~1,EffectiveDate:9/1/2018 Department: ApprovlnResponslScope: g Officer:bleAgent: 3364-133-103 Pharmacy Chief
More informationESPEN Congress The Hague 2017
ESPEN Congress The Hague 2017 Specific needs of patients with chronic disease Drug Nutrient interactions R. Witkamp (NL) Drug Nutrient interactions Prof dr. Renger Witkamp Nutrition and Pharmacology @rengerwitkamp
More informationALLERGIC CONJUNCTIVITIS AGENTS
2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops
More informationAnxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia
Anxiolytic, Sedative and Hypnotic Drugs Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia Anxiolytics: reduce anxiety Sedatives: decrease activity, calming
More informationDrugs Found in Medical Examiner Cases
s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam
More informationDementia Pharmacotherapy
Dementia Pharmacotherapy 1 early therapeutic interventions can maximize pharmacologic efficacy with these agents 2 Selecting a Medication Not enough evidence to recommend one agent over another based on
More informationAPPENDIX E: HEALTHCARE PRACTITIONER- REPORTED REDUCTION OF PAIN MEDICATION
Contents Appendix E: Healthcare Practitioner-Reported Reduction of Pain Medication... E-1 Appendix E: Healthcare Practitioner- Reported Reduction of Pain Medication Note: Word choice and spellings have
More informationGuidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence
Drug Gene(s)/Level of evidence Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Haloperidol CYP2D6 ( SLC6A5 ( 2D6: DPWG guidelines Reduce dose by 50% in PMs Aripiprazole
More informationCONTRAINDICATIONS TABLE
CONTRAINDICATIONS TABLE Generic Name Brand Name Contraindications Amphetamine Salts Adderall, Adderall XR Hypersensitivity to amphetamine, dextroamphetamine, or other sympathomimetic amines Advanced arteriosclerosis
More informationVNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019
VNSNY CHOICE FIDA Complete Step Therapy Requirements Effective: 04/01/2019 Updated 03/2019 AMANTADINE ER OSMOLEX ER 129 MG, EXTENDED RELEASE OSMOLEX ER 193 MG, EXTENDED RELEASE OSMOLEX ER 258 MG, EXTENDED
More informationRiesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
More informationStep Therapy Requirements
Step Therapy Requirements Denver Health Medicare Choice (HMO SNP)/Medicare Select (HMO) Effective: 09/01/2017 Updated 08/2017 ANTICONVULSANTS Aptiom 200 mg tablet Aptiom 400 mg tablet Aptiom 600 mg tablet
More informationMaking Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics. Session Objectives. January 2018
Making Sense of the Long Term Care Mega Rule: Unnecessary Drugs & Psychotropics Bridget McCrate Protus, PharmD, MLIS, BCGP, CDP Director of Drug Information Optum Hospice Pharmacy Services Session Objectives
More informationBree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT
Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup Opioid Prescribing Metrics - DRAFT Definitions: Days Supply: The total of all opioid prescriptions dispensed during the calendar quarter
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationFirstCarolinaCare Insurance Company. Step Therapy Requirements
FirstCarolinaCare Insurance Company Step Therapy Requirements Effective: 12/01/2018 ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION
More informationPrescribing Drugs to the Elderly
Answers to your questions from University of Toronto experts Prescribing Drugs to the Elderly Can drugs do more harm than good? M.A. is a 90-year-old man living at home. He has dementia and due to wandering
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationSymptom Management Challenges at End-of-Life
Symptom Management Challenges at End-of-Life Amanda Lovell, PharmD, BCGP Clinical Pharmacist- Inpatient Units Optum Hospice Pharmacy Services February 15, 2018 Hospice Pharmacy Services Objectives Identify
More informationSanta Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E
Santa Clara Family Health Plan Cal MediConnect Formulary List of Step Therapy Requirements Effective: 12/01/2018 13027.12E ANTICONVULSANTS APTIOM 200 MG TABLET APTIOM 400 MG TABLET APTIOM 600 MG TABLET
More informationSouth London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
More informationANTICONVULSANTS. Details
ANTICONVULSANTS APTIOM 200 MG APTIOM 400 MG APTIOM 600 MG APTIOM 800 MG BANZEL 200 MG BANZEL 40 MG/ML ORAL SUSPENSION BANZEL 400 MG FYCOMPA 0.5 MG/ML ORAL SUSPENSION FYCOMPA 10 MG FYCOMPA 12 MG FYCOMPA
More informationCardiovascular Health and Diabetes Screening for People with Schizophrenia
Cardiovascular Health and Diabetes Screening for People with Schizophrenia The percentage of members 25 years and older with a schizophrenia diagnosis and who were prescribed any antipsychotic medication,
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationInsomnia: Updates in Medical Management. Michael Newnam M.D.
Insomnia: Updates in Medical Management Michael Newnam M.D. Sleep Neurobiology Delicate balance of excitatory and inhibitory neurotransmitters that control the switch between wakefulness and sleep Circadian
More informationCHAPTER 4 PAIN AND ITS MANAGEMENT
CHAPTER 4 PAIN AND ITS MANAGEMENT Pain Definition: An unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Types of Pain
More informationToo Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities
Too Many Meds? How to Prevent Polypharmacy in People with Intellectual/Developmental Disabilities One definition of polypharmacy is using more medications than is medically necessary. However, it can be
More informationMedications: The Dark Side
Medications: The Dark Side Robert P. Smith, MD Potential Mechanisms of Drug Effects Metabolic effects Alterations of Immunologic factors in CNS Interference with synaptic transmission Excess dopaminergic
More information